🇺🇸 FDA
Patent

US 10512669

Blockade of inflammatory proteases with cyclic peptides

granted A61KA61K38/10A61K38/12

Quick answer

US patent 10512669 (Blockade of inflammatory proteases with cyclic peptides) held by The Regents of the University of California expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/10, A61K38/12, A61K38/1729, A61K38/55